Spironolactone Tablet, Film Coated
Product Images NDC 68382-660

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68382-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 01)

Chemical structure of spironolactone is shown, depicting the molecular framework with several rings and functional groups including ketone and thioester moieties, consistent with the active ingredient spironolactone.*

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)

A Kaplan-Meier survival curve comparing the probability of an event over time (months) between two groups: one receiving spironolactone (n=822) and the other receiving placebo (n=841). The graph shows higher survival probability in the spironolactone group, with a log-rank p-value less than 0.001.*

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)

A forest plot chart displaying hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study comparing spironolactone and placebo. Subgroups include age, sex, race, LVEF, heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitor, and beta blocker use. The horizontal axis measures HR from 0.2 to 1.4, indicating spironolactone better results to the left and placebo better results to the right.*

FDA Label Image

Image4 (B9a028ee 5720 4b9e A625 F7130aafd084 04)

Label for Spironolactone Tablets, USP 25 mg film-coated tablets by Zydus Pharmaceuticals (USA) Inc. The label shows the dosage strength (25 mg), a white round tablet imprinted with "660", and packaging information for 100 tablets, prescription only. It includes storage, handling, and manufacturer details from Cadila Healthcare Ltd., India.*

FDA Label Image

Image5 (B9a028ee 5720 4b9e A625 F7130aafd084 05)

Label for Spironolactone Tablets, USP 50 mg film-coated tablets by Zydus Pharmaceuticals. The label shows a single oval white tablet embossed with "661" and details that the bottle contains 100 tablets for oral use. Manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. Storage and handling instructions are included.*

FDA Label Image

Image6 (B9a028ee 5720 4b9e A625 F7130aafd084 06)

Packaging label for Spironolactone Tablets, USP 100 mg oral film-coated tablets. The label shows an image of the round, white tablets embossed with '662' on one side and a score line on the other. The bottle contains 100 tablets, labeled Rx only. The product is manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. Storage instructions and safety warnings are also included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.